Analysis for Respiratory Transmittable Diseases via Mass Spectrometry

Authors

  • Kriti Gupta

Abstract

Microbial identification in clinical diagnostic laboratories has mainly relied on conventional phenotypic and gene sequencing identification techniques. The development of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) devices has revolutionized the repetitive identification of microorganisms in clinical microbiology laboratories by introducing an easy, rapid, high throughput, low-cost, and effective identification technique. This technology has been modified to the restraint of clinical diagnostic laboratories and has likely to replace or complement conventional identification techniques for both bacterial and fungal strains. In recent advances of MALDI-TOF-MS as the laboratory diagnostic tool for the rapid laboratory diagnosis of microorganisms associated with respiratory infectious diseases, with the focus on rapid identiï¬cation of pathogenic bacteria and molecular markers discovery using MALDI-TOF-MS. With the advanced technologies such as MALDI-TOF, early and targeted therapies are based on rapid identification of pathogens and could lead to quick and effective treatment of respiratory infections and better patient management. Keywords: Respiratory infectious diseases, rapid laboratory diagnosis, pathogenic bacteria Cite this Article Kriti Gupta. Analysis for Respiratory Transmittable Diseases via Mass Spectrometry. Research & Reviews: Journal of Microbiology and Virology. 2017; 7(1): 26–30p.

Downloads

Published

2017-05-31

Issue

Vol. 7 No. 1 (2017)

Section

Review Articles

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

·         I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.

·         I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).

·         I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.

·          I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

_______________

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.